FFRct vs Withings Scan Monitor

HeartFlow FFRct integrates into the CCTA workflow by securely receiving scan data, processing it in the cloud, and delivering personalized 3D models and FFRct values, which can be integrated into PACS and EMR systems for diagnostic review and treatment planning. Withings Scan Monitor devices, part of their RPM solution, automatically synchronize patient data to a cloud platform and mobile app, offering seamless integration with virtually all EHR platforms for direct data transfer, reduced manual entry, and streamlined clinical workflows.

HeartFlow FFRct is a non-invasive diagnostic tool for coronary artery disease (CAD), providing FFRct values to assess blood flow and guide revascularization decisions with high diagnostic accuracy (e.g., 81-86% accuracy per patient, 84-87% sensitivity, and 81-86% specificity in studies like NXT and PACIFIC). Withings Scan Monitor is primarily used for remote patient monitoring, offering FDA-cleared ECG for Atrial Fibrillation (AFib) detection, heart rate, and other vital health metrics. The ScanWatch's AFib detection algorithm demonstrated high sensitivity and specificity in clinical studies, though some recordings may be inconclusive.

For HeartFlow FFRct, physicians and staff would need training on interpreting the personalized 3D models and FFRct values, and integrating these insights into their diagnostic and treatment algorithms for CAD. For Withings Scan Monitor, the learning curve for physicians involves understanding how to monitor and act upon continuous vital sign and ECG data from patient devices, typically through a user-friendly RPM dashboard, while patients find the devices easy to use.

HeartFlow FFRct deployment involves a local Virtual Appliance at each site for secure CCTA data transfer to its cloud-based processing network, requiring considerations for network infrastructure and data security across sites. Withings Scan Monitor, as part of an RPM solution, focuses on managing numerous patient-owned devices with cloud synchronization, necessitating a scalable system for patient onboarding, data aggregation, and physician review across a large patient base, with options for direct-to-member dropshipping or bulk delivery.

HeartFlow FFRct has been adopted by over 1,400 institutions globally and is supported by over 600 peer-reviewed publications and numerous clinical studies, including large real-world registries like FISH&CHIPS and ADVANCE, providing extensive evidence of its clinical and economic value. Withings Health Solutions offers case studies and research studies on its website, demonstrating the impact of its RPM solutions in various therapeutic areas and real-world deployments.